Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig L Slingluff

Showing results (41-50 of 225) with videos related to

Pageof 23
Sort By:
Clinical Trials (London, England)|December 1, 2012
Usefulness of prestudy assessment of patient willingness to undergo tissue biopsy for correlative studies in a melanoma vaccine trialJoshua M Judge, Kimberly A Chianese-Bullock, Anneke T Schroen, et al.
Surgery|February 6, 2017
Surgery investigators funded through the National Institutes of Health: A rebirthYinin Hu, Brandy L Edwards, Kevin Hu, et al.
Melanoma Research|January 25, 2017
The heterogeneity of tumor-infiltrating CD8+ T cells in metastatic melanoma distorts their quantification: how to manage heterogeneity?Joseph M Obeid, Yinin Hu, Gulsun Erdag, et al.
International Journal of Cancer|July 23, 2013
T cells in the human metastatic melanoma microenvironment express site-specific homing receptors and retention integrinsElise P Salerno, Walter C Olson, Chantel McSkimming, et al.
Cancer Control : Journal of the Moffitt Cancer Center|March 22, 2002
Immunotherapy for melanomaChristina J Kim, Sophie Dessureault, Dimitry Gabrilovich, et al.
Journal for Immunotherapy of Cancer|March 20, 2023
Peptide emulsions in incomplete Freund's adjuvant create effective nurseries promoting egress of systemic CD4<sup>+</sup> and CD8<sup>+</sup> T cells for immunotherapy of cancerMarit M Melssen, Caroline T Fisher, Craig L Slingluff, et al.
Journal for Immunotherapy of Cancer|March 12, 2022
The vaccine-site microenvironment: impacts of antigen, adjuvant, and same-site vaccination on antigen presentation and immune signalingMax O Meneveau, Pankaj Kumar, Kevin T Lynch, et al.
Journal of Cutaneous Pathology|March 13, 2009
Subclassification of desmoplastic melanoma: pure and mixed variants have significantly different capacities for lymph node metastasisEvan George, Susannah E McClain, Craig L Slingluff, et al.
Cancer Immunology, Immunotherapy : CII|October 23, 2016
Heterogeneity of CD8<sup>+</sup> tumor-infiltrating lymphocytes in non-small-cell lung cancer: impact on patient prognostic assessments and comparison of quantification by different sampling strategiesJoseph M Obeid, Nolan A Wages, Yinin Hu, et al.
American Journal of Surgery|May 2, 2015
Recent trends in National Institutes of Health funding for surgery: 2003 to 2013Yinin Hu, Brandy L Edwards, Kendall D Brooks, et al.
Pageof 23

Showing results (41-50 of 225) with videos related to

Sort By:
Pageof 23
Clinical Trials (London, England)|December 1, 2012
Usefulness of prestudy assessment of patient willingness to undergo tissue biopsy for correlative studies in a melanoma vaccine trialJoshua M Judge, Kimberly A Chianese-Bullock, Anneke T Schroen, et al.
Surgery|February 6, 2017
Surgery investigators funded through the National Institutes of Health: A rebirthYinin Hu, Brandy L Edwards, Kevin Hu, et al.
Melanoma Research|January 25, 2017
The heterogeneity of tumor-infiltrating CD8+ T cells in metastatic melanoma distorts their quantification: how to manage heterogeneity?Joseph M Obeid, Yinin Hu, Gulsun Erdag, et al.
International Journal of Cancer|July 23, 2013
T cells in the human metastatic melanoma microenvironment express site-specific homing receptors and retention integrinsElise P Salerno, Walter C Olson, Chantel McSkimming, et al.
Cancer Control : Journal of the Moffitt Cancer Center|March 22, 2002
Immunotherapy for melanomaChristina J Kim, Sophie Dessureault, Dimitry Gabrilovich, et al.
Journal for Immunotherapy of Cancer|March 20, 2023
Peptide emulsions in incomplete Freund's adjuvant create effective nurseries promoting egress of systemic CD4<sup>+</sup> and CD8<sup>+</sup> T cells for immunotherapy of cancerMarit M Melssen, Caroline T Fisher, Craig L Slingluff, et al.
Journal for Immunotherapy of Cancer|March 12, 2022
The vaccine-site microenvironment: impacts of antigen, adjuvant, and same-site vaccination on antigen presentation and immune signalingMax O Meneveau, Pankaj Kumar, Kevin T Lynch, et al.
Journal of Cutaneous Pathology|March 13, 2009
Subclassification of desmoplastic melanoma: pure and mixed variants have significantly different capacities for lymph node metastasisEvan George, Susannah E McClain, Craig L Slingluff, et al.
Cancer Immunology, Immunotherapy : CII|October 23, 2016
Heterogeneity of CD8<sup>+</sup> tumor-infiltrating lymphocytes in non-small-cell lung cancer: impact on patient prognostic assessments and comparison of quantification by different sampling strategiesJoseph M Obeid, Nolan A Wages, Yinin Hu, et al.
American Journal of Surgery|May 2, 2015
Recent trends in National Institutes of Health funding for surgery: 2003 to 2013Yinin Hu, Brandy L Edwards, Kendall D Brooks, et al.
Pageof 23